Funded Projects

Top Funded Faculty

Based on current funded research

Current Funded Research

Updated October 6, 2022
Data provided by University at Buffalo Sponsored Projects Services

Current Funded Research
Award Principal Investigator Award Name Award Type Sponsor Name Award Start Date Award End Date Total Cost
Balthasar, Dr. Joseph Center for Protein Therapeutics Nonfederal Multiple Sponsors 1-Sep-17 31-Aug-23 8,999,501.70
Balthasar, Dr. Joseph Pharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumors Federal National Cancer Institute 1-Jun-20 31-May-25 1,807,227.00
Balthasar, Dr. Joseph Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization Federal National Cancer Institute 1-Jun-21 31-May-26 1,817,098.00
Balu-Iyer, Dr. Sathy V. Tolerance Inducing Phosphatidylserine (TIPS): a nanoparticle-based platform for immunotherapy
Nonfederal Empire Discovery Institute
13-May-21 31-Dec-22 102,480.00
Balu-Iyer, Dr. Sathy V.
Lipid mediated oral tolerance
Federal National Institute of Allergy & Infectious Disease 16-Jun-22 31-May-27 2,327,530.00
Bednarczyk, Dr. Edward M.
C19: Chronic Disease Medication Utilization and the Novel Coronavirus Disease 2019 (COVID-19) Infection
Nonfederal American College of Clinical Pharmacy 01-Jan-21 31-Jul-23 600.00
Bednarczyk, Dr. Edward M. NYS Prescription Monitoring CE Program Federal Flow Through Island Peer Review Organization 1-Sep-21 31-Dec-23 188,394.00
Bies, Dr. Robert R. Physiologically-based model of the female reproductive tract: vaginal and intrauterine delivery components- Support New Approaches to Improve Product Manufacturing and Quality Federal US Food and Drug Administration 26-Sep-18 25-Jan-24 940,749.00
Bies, Dr. Robert R. Pharmacokinetics of sedatives - Understanding a modifiable risk factor for pediatric delirium Federal Flow Through Childrens Research Institute 1-Sep-19 31-Jul-24 47,894.00
Bies, Dr. Robert R.
Long Acting Film Technology for Contraception and HIV Prevention (LATCH)
Federal Flow Through
Magee-Womens Research Institute and Foundation
1-Feb-21 31-Jan-23 129,518.00
Bies, Dr. Robert R.
Evaluation of safety and pharmacokinetics of naltrexone implant
Federal Flow Through
Research Foundation for Mental Hygiene
1-Mar-21 28-Feb-23 143,325.00
Bies, Dr. Robert R. The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC) Federal Flow Through Trustees of Indiana University 10-Sep-2021 31-Jul-26 1,920,718.00
Bies, Dr. Robert R.
Population Pharmacokinetic Modeling and Clinical Trial Simulation to optimize HIV Prevention in Pregnancy and Postpartum
Federal Flow Through Johns Hopkins University 1-Aug-21 31-Dec-22 110,009.00
Bies, Dr. Robert R. Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and eXcellence, MATRIX Federal Flow Through Magee-Womens Research Institute and Foundation 01-Dec-2021 31-Dec-26 993,854.00
Cha, Dr. Raymond FELLOWSHIP for Melissa Stein (AFPE Gateway to Research)
Nonfederal American Foundation Pharmaceutical Education 01-Jul-22 30-Jun-23 5,000.00
Jacobs, Dr. David Matthew
A qualitative study to understand patient and social factors related to nebulizer use at the transition of care in COPD
Nonfederal Mylan Incorporated 15-Nov-19 31-Dec-22 60,786.00
Jacobs, Dr. David Matthew Integrative Informatics Approach to Predict Readmissions and Improve Outcomes in COPD Federal National Heart Lung and Blood Institute 1-Apr-21 31-Mar-26 962,055.00
Jusko, Dr. William J. Mechanistic Pharmacokinetics and Pharmacodynamics Federal National Institute of General Medical Sciences 1-May-19 30-Apr-24 2,891,677.00
Jusko, Dr. William J. Training Program in Pharmacokinetics and Pharmacodynamics Nonfederal GlaxoSmithKline 3-Feb-21 2-Feb-23 255,200.00
Ma, Dr. Qing Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV Federal National Institute on Aging 1-May-20 28-Feb-25 4,006,139.00
Ma, Dr. Qing Bictegravir in the Elderly Living with HIV: Impact of Polypharmacy and Multimorbidity Nonfederal Gilead Sciences Incorporated 1-Oct-19 30-Sep-23 155,175.00
Mager, Dr. Donald E. Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments Federal Flow Through Childrens Hospital of Boston 1-Sep-18 30-Jun-23 590,409.00
Mager, Dr. Donald E. Optimizing GVHD Prevention with Systems Pharmacology Models Federal Flow Through Beckman Research Institute of the City of Hope 1-Jun-19 31-May-24 543,822.00
Mager, Dr. Donald E.
Mechanistic PKPD modelling of biologic treatments in lymphoid leukemia for better understanding of efficacy and safety
Foreign Institut de Recherches Internatioales Servier 1-Aug-19 30-Nov-22
Meanay, Dr. Calvin J. Optimizing Vancomycin Use and Clinical Outcomes in Hemodialysis Patients
Nonfederal American College of Clinical Pharmacy
1-Jan-21 31-Dec-22 3,000.00
Morse, Dr. Gene Global Infectious Diseases Research Training Program Federal Fogarty International Center 11-Apr-18 28-Feb-23 1,125,653.00
Morse, Dr. Gene
ACTG Precautionary and Prohibited Medications Database
Federal Flow Through
Regents of the University of California Los Angeles
1-Dec-20 30-Nov-22 380,000.00
Morse, Dr. Gene ACTG Pharmacology Specialty Laboratory Federal Flow Through Regents of the University of California Los Angeles 1-Dec-20 30-Nov-27 2,003,875.00
Morse, Dr. Gene
C19: WNY COVID-19 Research Collaborative
Nonfederal John R. Oishei Foundation
1-Jun-21 31-Dec-22 54,450.00
Morse, Dr. Gene A Pilot Study to Investigate the Pharmacokinetic Properties of single- and multi-dose administration of a commercially available full-spectrum hemp-based CBD extract in Healthy Volunteers Nonfederal Dent Neuroscience Research Center 11-Aug-2021 30-Nov-22 63,468.00
Morse, Dr. Gene University of Rochester HIV/AIDS Clinical Trial Unit - AWD00003932 Federal Flow Through University of Rochester 01-Dec-2020 30-Nov-27 108,295.00
Morse, Dr. Gene C19: NYU: CBD, Morphine, Hydrocodone, and Oxycodone levels in human plasma samples Nonfederal New York University 01-Dec-2021 30-Apr-23 38,000.00
Morse, Dr. Gene
HIV Clinical Pharmacology & Therapeutics Research Training Program
Federal Fogarty International Center 1-Mar-22 31-Jan-27 1,580,866.94
Morse, Dr. Gene
Clinical Pharmacology Quality Assurance (CPQA)
Federal National Institute of Allergy & Infectious Disease
30-May-22 29-May-29 13,062,971.00
Morse, Dr. Gene
LC-MS/MS Assay Development and Validation for CBD and CBD hydroxy metabolite
Nonfederal Ananda Scientific 26-Apr-22 25-Jul-23 62,441.00
Qu, Dr. Jun GMPS-GMPR axis melanoma progression and therapy Federal Flow Through Wake Forest University Health Sciences 23-Nov-18 30-Apr-23 102,352.00
Qu, Dr. Jun Highly sensitive multiplexed targeted mass spectrometric assays of proteins/peptides of significance in obesity research Federal Flow Through Pacific Northwest National Laboratory 19-Feb-20 31-Jul-23 618,520.00
Qu, Dr. Jun Extracellular Vesicle treatment and age-related neuropathology in non-human primates Federal Flow Through Trustees of Boston University 15-Sep-20 30-Apr-25 214,632.00
Ramanathan, Dr. Murali The Metabolomics-Neurofilaments-Neurodegeneration Nexus in Multiple Sclerosis Progression Federal US Army Medical Research Acquisition Activity 1-Jul-20 30-Jun-23 957,000.00
Shah, Dr. Dhavalkumar
Development of a quantitative systems pharmacology (QSP) Model to Support Clinical Translation of adeno-associated virus (AAV) Vectorized Brain Delivery of Anti-a-Synuclein (AS) Antibody
Foreign AstraZeneca UK Limited 13-Jun-20 31-Oct-22 289,920.00
Shah, Dr. Dhavalkumar
Development of organ-specific quantitative systems toxicology models for antibody-drug conjugates
Nonfederal AstraZeneca Pharmaceuticals LP
1-Apr-22 31-Mar-25 465,771.00
Sprowl, Dr. Jason Arthur Regulation of hepatic uptake transporters by tyrosine kinases Federal National Institute of General Medical Sciences 15-Sep-2021 31-Aug-26 2,321,588.00
Straubinger, Dr. Robert M.
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development
Federal National Cancer Institute 21-Dec-18 30-Nov-22 398,683.00
Tornatore, Dr. Kathleen M. Age and Race Influences on Immunosuppression after Renal Transplant Federal National Institute on Aging 15-Aug-18 30-Jun-23 3,507,814.00
Tsuji, Dr. Brian T. Novel Strategies for Antibiotic Combinations to Combat Gram-negative Superbugs Federal National Institute of Allergy & Infectious Disease 20-Dec-19 30-Nov-24 3,920,362.00
Tsuji, Dr. Brian T.
Exploitation of multiple heteroresistance for effective antibiotic combination therapy
Federal Flow Through Emory University 1-Jul-20 30-Nov-22 245,091.00
Tsuji, Dr. Brian T.
Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa
Federal National Institute of Allergy & Infectious Disease 24-May-22 30-Apr-27 3,850,992.00
Woo, Dr. Sukyung Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition Federal National Cancer Institute 01-Dec-2021 30-Nov-26 2,018,141.00
You, Dr. Young Jae
Singlet Oxygen-cleavable Prodrugs for Treating Non-Muscle Invasive Bladder Cancers
Federal National Cancer Institute 13-Jul-22 30-Jun-27 2,104,600.00